SOX2 and cancer: In preclinical settings, it has shown to reduce the expression of stemness genes β-catenin, NANOG, smoothened and sex-determining region Y-box protein 2 (Sox2), impede self-renewal and survival of various cancer cells including HCC cells in vitro, as well as prevent cancer relapse and metastasis in vivo [85].